Sofosbuvir and Ribavirin Prevent Recurrence of HCV Infection After Liver Transplantation: An Open-Label Study

Overview of attention for article published in Gastroenterology, September 2014

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

So far, Altmetric has seen 9 news stories from 9 outlets.

A 24-week course of sofosbuvir and ribavirin can eliminate hepatitis C virus (HCV) infection in two-thirds of patients who…

A 24-week course of sofosbuvir and ribavirin can eliminate hepatitis C virus (HCV) infection in two-thirds of patients who…

Sofosbuvir and ribavirin administered before liver transplantation prevented posttransplantation recurrence of hepatitis C…

Bethesda, MD (Jan. 9, 2015) -- A 24-week course of sofosbuvir and ribavirin can eliminate hepatitis C virus (HCV) infection in…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 5 additional news stories.